全文获取类型
| 收费全文 | 68678篇 |
| 免费 | 3630篇 |
| 国内免费 | 1542篇 |
专业分类
| 耳鼻咽喉 | 406篇 |
| 儿科学 | 1399篇 |
| 妇产科学 | 1223篇 |
| 基础医学 | 4430篇 |
| 口腔科学 | 1334篇 |
| 临床医学 | 4808篇 |
| 内科学 | 14030篇 |
| 皮肤病学 | 643篇 |
| 神经病学 | 3196篇 |
| 特种医学 | 1249篇 |
| 外国民族医学 | 7篇 |
| 外科学 | 8214篇 |
| 综合类 | 7585篇 |
| 现状与发展 | 2篇 |
| 一般理论 | 1篇 |
| 预防医学 | 5138篇 |
| 眼科学 | 1179篇 |
| 药学 | 11099篇 |
| 52篇 | |
| 中国医学 | 5830篇 |
| 肿瘤学 | 2025篇 |
出版年
| 2024年 | 97篇 |
| 2023年 | 943篇 |
| 2022年 | 1396篇 |
| 2021年 | 2471篇 |
| 2020年 | 1966篇 |
| 2019年 | 3802篇 |
| 2018年 | 3259篇 |
| 2017年 | 2602篇 |
| 2016年 | 1806篇 |
| 2015年 | 1665篇 |
| 2014年 | 3671篇 |
| 2013年 | 3406篇 |
| 2012年 | 3483篇 |
| 2011年 | 3806篇 |
| 2010年 | 2812篇 |
| 2009年 | 2485篇 |
| 2008年 | 2352篇 |
| 2007年 | 2274篇 |
| 2006年 | 1920篇 |
| 2005年 | 1624篇 |
| 2004年 | 1222篇 |
| 2003年 | 1111篇 |
| 2002年 | 897篇 |
| 2001年 | 707篇 |
| 2000年 | 572篇 |
| 1999年 | 488篇 |
| 1998年 | 387篇 |
| 1997年 | 348篇 |
| 1996年 | 304篇 |
| 1995年 | 284篇 |
| 1994年 | 270篇 |
| 1993年 | 199篇 |
| 1992年 | 172篇 |
| 1991年 | 177篇 |
| 1990年 | 134篇 |
| 1989年 | 118篇 |
| 1988年 | 98篇 |
| 1985年 | 1501篇 |
| 1984年 | 2528篇 |
| 1983年 | 2336篇 |
| 1982年 | 1752篇 |
| 1981年 | 1834篇 |
| 1980年 | 1517篇 |
| 1979年 | 1338篇 |
| 1978年 | 1158篇 |
| 1977年 | 669篇 |
| 1976年 | 1110篇 |
| 1975年 | 984篇 |
| 1974年 | 818篇 |
| 1973年 | 782篇 |
排序方式： 共有10000条查询结果，搜索用时 31 毫秒
41.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461
Background
The purpose of the study was to evaluate the association between fetal echocardiographic measurements and the need for intervention (primary coarctation repair, staged coarctation repair, or catheter intervention) in prenatally diagnosed coarctation of the aorta.Methods
A single-centre retrospective cohort study (2005-2015) of 107 fetuses diagnosed with suspected coarctation of the aorta in the setting of an apex-forming left ventricle and antegrade flow across the mitral and aortic valves.Results
Median gestational age at diagnosis was 32 weeks (interquartile range, 23-35 weeks). Fifty-six (52%) did not require any neonatal intervention, 51 patients (48%) underwent a biventricular repair. In univariable analysis, an increase in ascending aorta (AAo) peak Doppler flow velocity (odds ratio [OR], 1.40 [95% confidence interval [CI], 1.05-1.91] per 20 cm/s; P = 0.03) was associated with intervention. No intervention was associated with larger isthmus size (OR, 0.23; P < 0.001), transverse arch diameter (OR, 0.23; P < 0.001), and aortic (OR, 0.72; P = 0.02), mitral (OR, 0.58; P = 0.001), and AAo (OR, 0.53; P < 0.001) z-scores. In multivariable analysis, higher peak AAo Doppler (OR, 2.51 [95% CI, 1.54-4.58] per 20 cm/s; P = 0.001) and younger gestational age at diagnosis (OR, 0.81 [95% CI, 0.70-0.93] per week; P = 0.005) were associated with intervention, whereas a higher AAo z-score (OR, 0.65 [95% CI, 0.43-0.94] per z; P = 0.029) and transverse arch dimension (OR, 0.44 [95% CI, 0.18-0.97]; P = 0.05) decreased the risk of intervention.Conclusions
In prenatally suspected coarctation, the variables associated with intervention comprised smaller AAo and transverse arch size, earlier gestational age at diagnosis, and the additional finding of a higher peak AAo Doppler. 相似文献42.
43.
44.
45.
46.
Background
Total knee arthroplasty is a treatment option for debilitating arthritis. In the postoperative period, patients experience moderate to severe pain affecting the rehabilitation, hospital stay, and patient satisfaction. This study aims at utilizing current best evidence to determine whether adductor canal block (ACB) or periarticular injection (PAI) is a better modality for managing short-term postoperative pain and opioid consumption.Methods
Embase, MEDLINE, HealthStar, Emcare, and PubMed were searched for randomized controlled trials from 1946 to August 2018, for literature addressing the comparison of ACB and PAI for pain management in the setting of total knee arthroplasty. A systematic review and meta-analysis were performed.Results
Six studies were included in our meta-analysis. When examining the combined visual analog scale (VAS) pain values for each group, analysis demonstrated greater reduction in scores for the PAI group, and the difference was statistically significant (P = .001). When comparing the VAS scores of subgroups analyzed at specific periods in time, there was a trend toward lower VAS scores in subgroups analyzed at 24 hours and 48 hours postoperatively (at rest and at movement) in the PAI group. Overall opioid consumption was lower in the PAI group, with demonstrated statistical significance (P = .03). When comparing the postoperative subgroups, there was a trend toward decreased opioid use in the PAI group, with 13.25% less opioid use at 48 hours and 9.5% less opioid use at 24 hours.Conclusion
PAI could significantly improve postoperative pain and opioid consumption when compared with ACB. Additional, high-quality studies are required to further address this topic. 相似文献47.
目的 探讨电针复合靶控输注（Target Controlled Infusion， TCI）在单肺通气食管癌开胸手术麻醉中的应用价值。方法 选取于我院拟行单肺通气食管癌开胸切除手术患者60例作为研究对象。随机将其分为试验组与对照组，对照组30例采取气管插管全麻及TCI靶控输注维持麻醉深度，试验组30例则在对照组方案基础上辅助电针麻醉，记录两组患者手术麻醉时间、药物用量、苏醒时间、并发症；以及术前（TⅠ）、插管前即刻（TⅡ）、插管后1 min（TⅢ）、切皮即刻（TⅣ）、去骨时（TⅤ）、拔管即刻（TⅥ）时平均动脉压（MAP）、平均心率（HR）、BIS值；术前、术后1天、术后3天简易智能精神状态检查量表（MMSE）；并于麻醉诱导前（T0）、手术开始2 h（T1）、术后1天（T2）、术后3天（T3）时抽取患者外周静脉血检测IL-1β、IL-6、IL-10、TNF-α浓度。结果 试验组手术用时、麻醉时间略低于对照组，但差异无统计学意义（P>0.05），试验组异丙酚、舒芬太尼用量以及苏醒时间均明显低于对照组（P<0.05）；TⅡ时两组平均动脉压（Mean Arterial Pressure， MAP）、心率（Heartrate， HR）较术前明显降低，且试验组MAP明显低于对照组（P<0.05），但两组TⅡ时HR比较无显著差异（P>0.05）；TⅢ、TⅥ时对照组MAP、HR明显高于TⅠ时，而试验组MAP、HR与TⅠ比较无显著差异（P>0.05）。术后1天、3天试验组简易智能精神状态检查量表（Mini-Mental State Examination， MMSE）评分低于对照组，有显著性差异（P<0.05）。T1、T2、T3时试验组白介素-1β（IL-1β）、白介素-6（IL-6）、肿瘤坏死因子（Tumor Necrosis Factor-α， TNF-α）水平明显低于对照组（P<0.05），白介素-10（IL-10）水平明显高于对照组（P<0.05）。结论 采用电针复合TCI靶控输注麻醉方案可有效提升单肺通气食管癌开胸手术麻醉效果，能够降低患者术后认知功能障碍发生风险。 相似文献
48.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献49.
50.